Pharmacological treatment of cocaine/crack addiction: analysis of pharmacotherapy in chemically dependent patients
DOI:
https://doi.org/10.33448/rsd-v11i10.32882Keywords:
Crack; Cocaine; Illicit drugs; Ibogaine.Abstract
Dependence caused by cocaine use represents a public health problem in several countries. Despite its high potential to cause dependence, there is still no clinical protocol for pharmacological treatment. However, from positive results, some clinicalstudieshavealreadybeendevelopedwiththepurposeofidentifyingpharmacologicaltherapies in order to minimize the desire to consume the substance. The pharmacological treatment of addictions consists of psychotropic drugs, which are controlled drugs that act on the Central Nervous System. These medications contribute to their duction of drug withdrawal symptoms, in addition to symptoms of any psychiatric comorbidities that the patient may present. In this sense, pharmacotherapy acts in the treatment of chemical dependence, complementing other activities that seek to improve the quality of life of patients. This study aimed to carry out a bibliographic survey on the pharmacological treatment of cocaine/crack addiction, taking into account the analysis of pharmacotherapy in chemically dependent patients. For this, publications available in the PUBMED, LILACS, and VHL databases were used for the period from 2012 to 2021. From the accomplishment of this research, it was concluded that despite the high incidence of users of drugs of abuse there is still no pharmacological treatment defined for cocaine/crack-dependent individuals, therefore, it is necessary to carry out more studies on the subject in order to reduce the symptoms of withdrawal from substance use.
References
Alves, F. A. F. (2018). Tratamento farmacológico da dependência por cocaína: um levantamento bibliográfico sobre ensaios clínicos. Universidade de Brasília. Trabalho de conclusão de curso (curso de Farmácia). 49 p.
Alves, H. N. P., Ribeiro, M., Castro, D. S. (2018). Cocaína e crack. Revista de Psicofarmacologia Clínica. Disponível em:
https://www.researchgate.net/publication/283173068_Cocaina_e_crack/link/562d973e08ae22b17034c52c/download. Acesso em 10 mai. 2022.
Associação Brasileira de Psiquiatria. (2011). Abuso e dependência: crack. Projeto diretrizes. Brasília: Conselho Federal de Medicina.
Barbosa, E., Abdala, P. V. (2021). Tratamento farmacológico eficaz no uso e manuseio do antietanol para usuários de crack. Diversità – Revista Multidisciplinar do Centro Universitário Cidade Verde. v.07, n.1. Disponível em: https://revista.unifcv.edu.br/index.php/revistapos/article/view/366/270. Acesso em 10 mai. 2022.
Bastos, F. I. P. M., Vasconcellos, M. T. L., De Boni, R. B., Reis, N. B., Coutinho, C. F. S. (2017). III Levantamento Nacional sobre o uso de drogas pela população brasileira. Rio de Janeiro: FIOCRUZ/ICICT, 528 p. Disponível em: https://portal.fiocruz.br; Acesso em: 28 Mai. 2020.
Blevins, D. Wang, X., Sharma, S. Ait-Daoud, N., (2019). Impulsiveness as a PredictorofTopiramate Response for Cocaine Use Disorder. The American JournalonAddictions, XX: 1–6.
Brasil. (2009). Ministério da Saúde. Coordenação Nacional de Saúde Mental, Álcool e Outras Drogas do Ministério da Saúde. O crack: como lidar com este grave problema. Coordenação Nacional de Saúde Mental, Álcool e Outras Drogas. Disponível em: http://portal.saude.gov.br/portal/saude/visualizartexto.cfm?idtxt=33717&janela=1. Acesso em 28 abr 2022.
Brum, C. N. (2015). Revisão narrativa da literatura: aspectos conceituais e metodológicos na construção do conhecimento da enfermagem. In: Lacerda, M. R., Costenaro, R. G. S. Metodologia de pesquisa para a enfermagem a saúde da teoria a prática. 1ª ed. Porto Alegre: Moriá, p.123-142.
Carroll, K. M., Nich, C., Shi, J. M., Eagan, D., Ball, S. A. (2016). A Randomized Factorial Trial of Disulfiram and Contingency Management toEnhanceCognitive Behavioral Therapy for Cocaine Dependence. HHS Public: Drug Alcohol Depend. Author manuscript; available in PMC. March, 01.
CID-10 / OMS, Organização Mundial de Saúde. (2007). Tradução Centro colaborador da OMS para a Classificação de Doenças em Português. 10, Ed. rev. – São Paulo: Editora da Universidade de São Paulo.
CFM, Conselho Federal de Medicina (2011). DIRETRIZES GERAIS MÉDICAS: Para Assistência Integral ao Dependente do Uso do Crack. Rev. CFM.
Chasin, A. A. da M., Silva, E. S. (2003). Estimulantes do Sistema Nervoso Central. Fundamentos de Toxicologia. 2. ed. São Paulo: Atheneu. Cap. 43, p. 239-249.
Cooper, D. A., Kimmel H. L., Manvich, D. F., Weinsheker, D., Howell, L. L. (2014). Effect sof pharmacologic dopamine b-hydroxylase inhibition on cocaine - induced reinstatementand dopamine neurochemistry in squirrelmonkeys. The journal of pharmacology and experimental therapeutics. J pharmacol exp. ther. 350:144–152, july.
Corkery, J. M. (2018). Ibogaine as a treatment for substancemisuse: Potentialbenefitsandpracticaldangers.Psychopharmacology, Drug Misuseand Novel Psycho active Substances Research Unit, School of Life and Medical Sciences, Universityof Hertfordshire. Hatfiel: Elsevier B.V..
Douaihy, A. B., Kelly, T. M., Sullivan, C. (2013). Medications for Substance Use Disorders. Social Work in Public Health, n. 28, p. 264–78.
Karila, L.; Leroy, C., Dubol, M., Trichard, C. Mabondo, A. Marill, C.,... Artiges, E., (2016). Dopamine Transporter Correlates and Occupancy by Modafinil in Cocaine-Dependent Patients: A Controlled Study With High-Resolution PET and [11C]-PE2I. Psychiatry Department, Orsay Hospital, Orsay, France-Université Paris. Neuropsychopharmacology.
Kimishimaa A., Olson, M. E., Janda, K. D. (2018). Investigations in to the efficacy of multi-component cocaine vacines. Author manuscript - Bioorg Med Chem Lett.
Knevitz, M. F., Buccini, D. F. (2018). Psicofármacos no tratamento da dependência química: uma revisão. RIES, Caçador, v.7, nº 1, p. 205-219, 2018. Disponível em: https://periodicos.uniarp.edu.br/index.php/ries/article/view/1124#:~:text=Resumo,atuar%20no%20tratamento%20das%20comorbidades. Acesso em 12 mai. 2022.
Knuijver, T., Schellekens, A., Belgers, M., Donders, R., Oosteren, T. V., Kramers, K., & Verkes, R. (2018). Letter to the Editors – Hallucinogen Persisting Perception Disorder After Ibogaine Treatment for Opioid Dependence. Journal of Clinical Psychopharmacology.
Leite, M. C. (1999). Cocaína e crack: dos fundamentos ao tratamento. 1 ed. Porto Alegre: Artes Médicas, p. 15-23.
Lingford-Hughes, A. R., Welch, S., Peters, L., Nutt, D. J. (2012). BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. Journal of Psychopharmacology, 26(7), p. 899–952.
Nuijten, M. Blanken, P., Brink, w. v., Goudriaan, A. E., Hendriks, V. M. (2016). Impulsivityandattentional bias as predictorsofmodafiniltreatmentoutcome for retentionanddrug use in crack-cocainedependentpatients: Resultsof a randomisedcontrolledtrial. Journal of Psychopharmacology. p.1–11.
Observatório Europeu da Droga e da Toxicodependência (EMCDDA). (2014). Relatório Europeu sobre Drogas - Tendências e evoluções. Disponível em: http://www.emcdda.europa.eu/publications/edr/trends-developments/2014. Acesso em 30 abr. 2022.
Riezzo, I., Fiore, C., De Carlo, D., Pascale, N., Neri, M., Turillazzi, E., & Fineschi, V. (2012). Sideeffectsofcocaine abuse: multiorgantoxicityandpathologicalconsequences. Current Medicinal Chemistry, v. 19, n. 33, p. 5624-5646.
Sangroula, D., Motiwala, F., Wagle, B., Shas, V. C., Hagi, K., & Lippmann, S. (2017). Modafinil Treatment of Cocaine Dependence: A Systematic Review and Meta-Analysis. Substance Use & Misuse. Disponível em: Disponível em: http://www.tandfonline.com/loi/isum20. Acesso em 03 jun. 2020.
Spronk, D. B., Van Wel, J. H. P., Ramaekers, J. G., & Verkes, R. J. (2013). Characterizing the cognitive effects of cocaine: a comprehensive review. Neuroscience & Bio behavioral Reviews, v. 37, n. 8, p.1838-1859.
Swift, R. M., Lewis, D. C. (2018). Farmacologia da Dependência e Abuso de Drogas. Disponível em: https://edisciplinas.usp.br/pluginfile.php/3319241/. Acesso em 05 mai. 2022.
Valério, A. T. C. (2014). Anatomia e farmacologia das "drogas" de abuso. Instituto Superior de Ciências da Saúde Egas Moniz. p.101.
United States Congress. (2004). The Neuropharmacology of Drugs of Abuse. In University Press ofthe Pacific (Ed.), Biological Components of Substance Abuse and Addiction. 2004. p. 19–35. Disponível em: https://www.princeton.edu/~ota/disk1/1993/9311/931105.PDF. Acesso em 01 mai. 2022.
Weiss, R. D., Mirin, S. M.; Bartel, R. L. (1994). Cocaine. 2 ed. Washington: American Psychiatric Press.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Allan Ricardo Rodrigues Gomes; Ricardo Guimarães Amaral; Luciana Nalone Andrade
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
